• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性疾病中血浆脂蛋白的磁共振波谱分析:方法学方面及临床相关性

Magnetic resonance spectroscopy of blood plasma lipoproteins in malignant disease: methodological aspects and clinical relevance.

作者信息

Engan T

机构信息

Department of Oncology, University Hospital of Trondheim, Norway.

出版信息

Anticancer Res. 1996 May-Jun;16(3B):1461-71.

PMID:8694514
Abstract

NMR spectroscopy of blood plasma has been extensively investigated in the last decade, mainly motivated by a hope that the method would aid in the diagnosis of malignant disease. Although the 1H NMR indices have failed as a tumor marker suitable for cancer screening due to low specificity, the method has great potential in cancer research. Its use outside research laboratories, however, is still very limited. Several methodological problems require special attention. 1H NMR spectroscopy lipid line widths are composite signals that reflect a continuum of general responses to different stimuli. Few studies on the fatty acid distribution in blood plasma in malignancy have been done, using the saturated and unsaturated regions of the 13C NMR spectrum. NMR spectroscopy of blood plasma might be valuable in practical clinical use. We suggest that this method could estimate effects on blood lipid profile following endocrine therapies in cancer patients.

摘要

在过去十年中,血浆的核磁共振光谱学得到了广泛研究,主要是出于该方法有助于恶性疾病诊断的期望。尽管由于特异性低,1H核磁共振指标未能作为适用于癌症筛查的肿瘤标志物,但该方法在癌症研究中具有巨大潜力。然而,其在研究实验室之外的应用仍然非常有限。几个方法学问题需要特别关注。1H核磁共振光谱学的脂质线宽是复合信号,反映了对不同刺激的一系列总体反应。利用13C核磁共振谱的饱和和不饱和区域,对恶性肿瘤患者血浆中脂肪酸分布的研究很少。血浆核磁共振光谱学在实际临床应用中可能具有价值。我们认为,这种方法可以评估癌症患者内分泌治疗后对血脂谱的影响。

相似文献

1
Magnetic resonance spectroscopy of blood plasma lipoproteins in malignant disease: methodological aspects and clinical relevance.恶性疾病中血浆脂蛋白的磁共振波谱分析:方法学方面及临床相关性
Anticancer Res. 1996 May-Jun;16(3B):1461-71.
2
Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.恶性肿瘤的检测。血浆的水抑制质子核磁共振波谱分析。
N Engl J Med. 1986 Nov 27;315(22):1369-76. doi: 10.1056/NEJM198611273152201.
3
[NMR research on blood plasma for tumor detection--a method for mass screening?].[用于肿瘤检测的血浆核磁共振研究——一种大规模筛查方法?]
Arch Geschwulstforsch. 1989;59(2):129-33.
4
Proton NMR spectroscopy of plasma lipoproteins: a marker of the immune function in cancer disease?血浆脂蛋白的质子核磁共振波谱:癌症疾病免疫功能的标志物?
Anticancer Res. 1994 Sep-Oct;14(5A):1839-51.
5
The NMR blood test for cancer: current status.用于癌症检测的核磁共振血液检测:现状
Cancer Cells. 1991 May;3(5):173-82.
6
[H-NMR spectroscopy of plasma cannot be used for cancer screening].血浆的氢核磁共振光谱法不能用于癌症筛查。
Bull Cancer. 1988;75(8):795-800.
7
Proton nuclear magnetic resonance spectroscopy of plasma lipoprotein: technical problems and potential interest in cancer disease.血浆脂蛋白的质子核磁共振波谱:技术问题及在癌症疾病中的潜在意义
Anticancer Res. 1996 May-Jun;16(3B):1451-60.
8
Lack of efficacy of water-suppressed proton nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors.血浆水抑制质子核磁共振波谱法检测恶性肿瘤的效能不足。
N Engl J Med. 1990 Apr 5;322(14):953-8. doi: 10.1056/NEJM199004053221403.
9
Artificial neural network analysis of 1H nuclear magnetic resonance spectroscopic data from human plasma.
Anticancer Res. 1996 May-Jun;16(3B):1473-7.
10
[Study on the malignant and normal rectum tissues using 1H NMR spectroscopy].[利用氢核磁共振波谱对恶性和正常直肠组织的研究]
Guang Pu Xue Yu Guang Pu Fen Xi. 2008 Feb;28(2):308-12.

引用本文的文献

1
Quantitative ¹H-NMR Spectroscopy for Profiling Primary Metabolites in Mulberry Leaves.¹H-NMR 波谱法分析桑叶中的主要代谢产物。
Molecules. 2018 Mar 2;23(3):554. doi: 10.3390/molecules23030554.
2
In Vitro and In Vivo (1)H-MR Spectroscopic Examination of the Renal Cell Carcinoma.肾细胞癌的体外和体内氢磁共振波谱检查
Int J Biomed Sci. 2012 Jun;8(2):94-108.